Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use

Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use

US Patent 6979451 · Granted Dec 27, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recycling of superabsorbent fibers with an extensional flow device2025
Methods for inhibiting conversion of choline to trimethylamine (TMA)2022
Methods for inhibiting conversion of choline to trimethylamine (TMA)2022
Methods for inhibiting conversion of choline to trimethylamine (TMA)2020
Methods for inhibiting conversion of carnitine to trimethylamine (TMA)2020
Methods for inhibiting conversion of choline to trimethylamine (TMA)2020
Methods for inhibiting conversion of choline to trimethylamine (TMA)2020
Methods for inhibiting conversion of choline to trimethylamine (TMA)2020
Bifidobacterium longum2019
Bifidobacterium longum2019
Compounds and methods for inhibiting production of trimethylamine2019
Compositions and methods for improving skin health2018